NCT06646055 2026-03-09
AK112 and Cadonilimab Combined With Chemotherapy for 1L Treatment of Metastatic Pancreatic Cancer
Akeso
Phase 1/2 Active not recruiting
Clinical Trials
4 trialsNCT05630183 2025-11-13
A Study of Botensilimab in Participants With Metastatic Pancreatic Cancer
Agenus Inc.
Phase 2 Active not recruiting
NCT04581343 2025-05-04
PanCAN-SR1
Pancreatic Cancer Action Network
Phase 1 Completed
NCT03450018 2024-05-24
SLC-0111-17-01
British Columbia Cancer Agency
Phase 1/2 Terminated